TEVA PHARMACEUTICAL INDUSTRIES LIMITED Gain (Loss) on Disposition of Assets
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Gain (Loss) on Disposition of Assets of $25.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-12.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2024-02-12
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) on disposition of assets for fiscal 2023 was $25.00M, a 38.89% increase from fiscal 2022.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) on disposition of assets for fiscal 2022 was $18.00M, a 157.14% increase from fiscal 2021.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) on disposition of assets for fiscal 2021 was $7.00M, a 36.36% decline from fiscal 2020.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED gain (loss) on disposition of assets for fiscal 2020 was $11.00M.
| Period end | Gain (Loss) on Disposition of Assets 12 month |
|---|---|
| 2023-12-31 | $25.00M 10-K · filed 2024-02-12 |
| 2022-12-31 | $18.00M 10-K · filed 2024-02-12 |
| 2021-12-31 | $7.00M 10-K · filed 2024-02-12 |
| 2020-12-31 | $11.00M 10-K · filed 2023-02-10 |
| 2019-12-31 | -$1.00M 10-K · filed 2022-02-09 |